Advertisement
For adults with severe hemophilia and pre-existing joint disease

Prophylaxis Linked to Improved Function, HRQoL in Hemophilia

0
Improved function, QoL, activity, pain but not joint structure in adults with hemophilia with joint disease
Minimal evidence is available for guidelines for electronic communication between patients and providers

Minimal Evidence for Electronic Communication Guidelines

0
Current guidelines for e-communication between patients, providers based on minimal evidence
The majority of melanomas arise from new lesions rather than existing moles

Most Melanomas Don’t Start As Existing Moles

0
More than two-thirds occur as new lesions, researchers find
Most patients are using online reviews as a first step to finding a new doctor

Proactive Approach Encouraged for Online Patient Reviews

0
Most patients use online reviews as first step to find new doctor; form an opinion from one to six reviews
The U.S. Food and Drug Administration on Wednesday approved the first gene therapy -- Kymriah (tisagenlecleucel) -- in the United States

FDA Approves First Gene Therapy in the United States

0
Kymriah approved for patients up to 25 years of age with refractory or relapsed B-cell precursor ALL
Many non-hormone options and therapies are available for the treatment of estrogen-depletion symptoms in breast cancer survivors

Options Available for Estrogen Depletion After Breast Cancer

0
Women should be encouraged to optimize lifestyle and should not be treated with hormone therapy
Patients with head and neck melanoma benefit from the introduction of initial staging using computed tomography

Computed Tomography Useful for Staging Head, Neck Melanoma

0
CT identifies more metastases, avoids unnecessary sentinel lymph node biopsies
Use of androgen-deprivation therapy may increase the risk of certain cardiovascular conditions in men with prostate cancer

Androgen-Deprivation Therapy May Carry Cardiovascular Risks

0
Findings in men with clinically localized prostate cancer initially under active surveillance
There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma in the era of highly-active antiretroviral therapy

ART Era Has Changed Secondary Cancers After Kaposi Sarcoma

0
Certain cancers -- ALL and cancers of the tongue, penis -- becoming more common
Six out of 10 U.S. teens ages 13 to 17 received one or more doses of a human papillomavirus vaccine in 2016

CDC: More U.S. Teens Starting HPV Vaccination

0
60.4 percent received one or more doses in 2016, but many not completing series